PT  - JOURNAL ARTICLE
AU  - Nash, Rebecca K
AU  - Cori, Anne
AU  - Nouvellet, Pierre
TI  - Estimating the epidemic reproduction number from temporally aggregated incidence data: a statistical modelling approach and software tool
AID  - 10.1101/2022.12.08.22283241
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.12.08.22283241
4099  - http://medrxiv.org/content/early/2022/12/13/2022.12.08.22283241.short
4100  - http://medrxiv.org/content/early/2022/12/13/2022.12.08.22283241.full
AB  - Background The time-varying reproduction number (Rt) is an important measure of epidemic transmissibility; it can directly inform policy decisions and the optimisation of control measures. EpiEstim is a widely used software tool that uses case incidence and the serial interval (SI, time between symptoms in a case and their infector) to estimate Rt in real-time. The incidence and the SI distribution must be provided at the same temporal resolution, which limits the applicability of EpiEstim and other similar methods, e.g. for pathogens with a mean SI shorter than the frequency of incidence reporting.Methods We use an expectation-maximisation algorithm to reconstruct daily incidence from temporally aggregated data, from which Rt can then be estimated using EpiEstim. We assess the validity of our method using an extensive simulation study and apply it to COVID-19 and influenza data. The method is implemented in the opensource R package EpiEstim.Findings For all datasets, the influence of intra-weekly variability in reported data was mitigated by using aggregated weekly data. Rt estimated on weekly sliding windows using incidence reconstructed from weekly data was strongly correlated with estimates from the original daily data. The simulation study revealed that Rt was well estimated in all scenarios and regardless of the temporal aggregation of the data. In the presence of weekend effects, Rt estimates from reconstructed data were more successful at recovering the true value of Rt than those obtained from reported daily data.Interpretation Rt can be successfully recovered from aggregated data, and estimation accuracy can even be improved by smoothing out administrative noise in the reported data.Funding MRC doctoral training partnership, MRC centre for global infectious disease analysis, the NIHR HPRU in Modelling and Health Economics, and the Academy of Medical Sciences Springboard, funded by the AMS, Wellcome Trust, BEIS, the British Heart Foundation and Diabetes UK.Competing Interest StatementAC has received payment from Pfizer for teaching on a course for mathematical modelling of infectious disease transmission and vaccination.Funding StatementRKN acknowledges funding from the Medical Research Council (MRC) Doctoral Training Partnership (REF:MR/N014103/1). AC acknowledges funding from the National Institute for Health Research (NIHR) Health Protection Research Unit in Modelling and Health Economics, a partnership between Public Health England, Imperial College London and LSHTM (REF:NIHR200908); the Academy of Medical Sciences Springboard scheme, funded by the AMS, Wellcome Trust, BEIS, the British Heart Foundation and Diabetes UK (REF:SBF005\1044); and the MRC Centre for Global Infectious Disease Analysis (REF:MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union; and acknowledges funding by Community Jameel. The views expressed are those of the author(s) and not necessarily those of the NIHR, Public Health England or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study uses both simulated data and openly available human data: Influenza incidence data were digitally extracted from: Riley P, Cost AA, Riley S. Intra-Weekly Variations of Influenza-Like Illness in Military Populations. Military Medicine. 2016 Apr 1;181(4):364-8. COVID-19 incidence data taken from the UK government website: https://coronavirus.data.gov.uk/details/casesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code to apply the method developed is available in the open-source R package EpiEstim: https://github.com/mrc-ide/EpiEstim. https://github.com/mrc-ide/EpiEstim